Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Kyle Clifford Cuneo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8264-6483; OpenAlex author ID A5082821643. Sources: ClinicalTrials.gov.

Their work

Papers
9 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2008: 1 trial · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 3 papers · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper

Papers 9

  1. Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer. Last author DOI 10.1016/j.adro.2023.101266↗
  2. Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resec… Co-author DOI 10.1016/j.ijrobp.2019.08.057↗
  3. Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Persona… Co-author DOI 10.3390/cancers12041011↗
  4. Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic C… Co-author DOI 10.1200/jco.19.00730↗
  5. Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC Carpet Chip. Co-author DOI 10.1002/adbi.201800228↗
  6. Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy. Co-author DOI 10.1016/j.ijrobp.2017.10.030↗
  7. Circulating Microvesicles from Pancreatic Cancer Accelerate the Migration and Proliferation of PANC-1 Cells. Co-author DOI 10.1021/acs.jproteome.8b00014↗
  8. Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy. Co-author DOI 10.1021/acs.jproteome.7b00024↗
  9. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Co-author DOI 10.1016/j.tranon.2014.07.005↗

Trials 1

  1. A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response Principal investigator NCT01209962↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Theodore Steven Lawrence · 7 shared papers, 2014–2023 · strength 0.66
  2. Vaibhav Sahai · 4 shared papers, 2018–2023 · strength 0.44
  3. Meredith Ann Morgan · 4 shared papers, 2017–2020 · strength 0.34
  4. Mark M. Zalupski · 4 shared papers, 2014–2020 · strength 0.31
  5. Hari Nathan · 2 shared papers, 2019–2020 · strength 0.19
  6. Clifford S. Cho · 2 shared papers, 2019–2020 · strength 0.19
  7. Rishi Das · 1 shared paper, 2023 · strength 0.18
  8. Filip Bednar · 1 shared paper, 2023 · strength 0.18
  9. Mingrui An · 2 shared papers, 2017–2018 · strength 0.17
  10. David M. Lubman · 2 shared papers, 2017–2018 · strength 0.17
  11. Jianhui Zhu · 2 shared papers, 2017–2018 · strength 0.17
  12. Sunitha Nagrath · 2 shared papers, 2018–2020 · strength 0.17
  13. Jiaqi Shi · 2 shared papers, 2018–2020 · strength 0.17
  14. Ines Lohse · 2 shared papers, 2017–2020 · strength 0.17
  15. Edgar Ben‐Josef · 2 shared papers, 2014–2018 · strength 0.12
  16. Diane M. Simeone · 2 shared papers, 2014–2018 · strength 0.10
  17. Lianette Rivera-Báez · 1 shared paper, 2020 · strength 0.10
  18. Sarah Owen · 1 shared paper, 2020 · strength 0.10
  19. Nguyen H. Tran · 1 shared paper, 2020 · strength 0.10
  20. Edward Jae-Hoon Kim · 1 shared paper, 2020 · strength 0.10
  21. Ravi Kiran Kaza · 1 shared paper, 2020 · strength 0.10
  22. Leslie A. Parsels · 1 shared paper, 2019 · strength 0.08
  23. Jonathan Maybaum · 1 shared paper, 2019 · strength 0.08
  24. Max S. Wicha · 1 shared paper, 2018 · strength 0.07
  25. Mina Zeinali · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.